Latest Articles
Cramping but No Period? Here’s 15 Possible Reasons Why - Prevention Magazine
Cramping but No Period? Here’s 15 Possible Reasons Why Prevention Magazine
Published: April 26, 2024, 7 a.m.
Pelvic Pain Education And New Period Products In Schools - Premier of Victoria
Pelvic Pain Education And New Period Products In Schools Premier of Victoria
Published: April 26, 2024, 7 a.m.
Tiffany Haddish opens up about facing health issues and sobriety - Rolling Out
Tiffany Haddish opens up about facing health issues and sobriety Rolling Out
Published: April 26, 2024, 7 a.m.
Tiffany Haddish Opens Up About 8 'Devastating' Miscarriages Amid Endometriosis Battle - Women's Health
Tiffany Haddish Opens Up About 8 'Devastating' Miscarriages Amid Endometriosis Battle Women's Health
Published: April 25, 2024, 7 a.m.
Tiffany Haddish Says She's Been Diagnosed With Endometriosis and Has Experienced 8 Miscarriages - Marie Claire
Tiffany Haddish Says She's Been Diagnosed With Endometriosis and Has Experienced 8 Miscarriages Marie Claire
Published: April 25, 2024, 7 a.m.
Tiffany Haddish Opens Up About 8 Miscarriages & Endometriosis - The Shade Room
Tiffany Haddish Opens Up About 8 Miscarriages & Endometriosis The Shade Room
Published: April 25, 2024, 7 a.m.
Actress Tiffany Haddish opens up on heartbreak of eight miscarriages amid endometriosis diagnosis - Tyla
Actress Tiffany Haddish opens up on heartbreak of eight miscarriages amid endometriosis diagnosis Tyla
Published: April 25, 2024, 7 a.m.
Dr Eskander on Pembrolizumab Plus Chemo in Advanced/Recurrent Endometrial Cancer - OncLive
Dr Eskander on Pembrolizumab Plus Chemo in Advanced/Recurrent Endometrial Cancer OncLive
Published: April 24, 2024, 7 a.m.
Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting - Investor Relations | Karyopharm Therapeutics
Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting Investor Relations | Karyopharm Therapeutics
Published: April 24, 2024, 7 a.m.
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses - Nature.com
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses Nature.com
Published: April 23, 2024, 7 a.m.
Link copied to clipboard!